Aram Mangasarian is the founder of TME Pharma. TME Pharma has raised $9M in total funding. Latest round: Growth. Backed by individual investors.
Aram Mangasarian is the CEO of TME Pharma N.V., a clinical-stage biotechnology company. The company focuses on developing novel therapies for cancer by targeting the tumor microenvironment (TME). TME Pharma recently completed a capital raise of €2.35 million gross through a private placement with professional investors and a public offering to retail investors in France via the PrimaryBid platform. This funding helps extend the company's financial visibility and supports ongoing clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library